NVE Corporation announced that it will release its financial results for the quarter ended June 30, 2024 on July 17, 2024 and hold a conference call later that day.

Discover why Zacks rates NVE Corp (NVEC) as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore how NVE Corp's growth prospects in the semiconductor industry remain promising, with strong dividend yield and solid cash position amid labor market challenges.

EDEN PRAIRIE, Minn., May 13, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today that its Board of Directors elected Kelly Wei, Ph.D. to join the Board, effective today, filling the unexpired term of Richard W. Kramp, who passed away recently. Dr. Wei will also serve on the Board’s Compensation Committee and Nominating and Corporate Governance Committee.

EDEN PRAIRIE, Minn., May 06, 2024 (GLOBE NEWSWIRE) --  NVE Corporation (Nasdaq: NVEC) announced with sadness that Richard W. Kramp, a member of the Company’s Board of Directors, passed away after an illness. Mr. Kramp was first elected to NVE’s Board in 2014 after a long and distinguished career in the medical device industry. Most recently, he was CEO of Synovis Life Technologies, Inc., a diversified medical device company, from 2007 to 2012.

EDEN PRAIRIE, Minn., April 24, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2024 on Wednesday, May 1, 2024 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.

EDEN PRAIRIE, Minn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and nine months ended December 31, 2023.

EDEN PRAIRIE, Minn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended December 31, 2023 on Wednesday, January 17, 2024 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.

Charlie Munger recently pointed investors to narrow group of stocks that he believes will position their portfolios to

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. SEALSQ Corp (NASDAQ: LAES) SEALSQ announced nine-month 2023 unaudited revenue of $22.1 million, a 20.4% increase from the 9-month 2022 period. Carlos Moreira, CEO of SEALSQ, said, “We are witnessing a robust and consistent customer demand for our semiconductors and Matter-related products, coupled with an upward trajectory in our market share.” The company’s stock has a 52-week low of $1.22 . RSI Value: 24.93 LAES Price ...

EDEN PRAIRIE, Minn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and six months ended September 30, 2023.

EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended September 30, 2023, on Wednesday, October 18, 2023, after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. T2 Biosystems, Inc. (NASDAQ: TTOO) shares gained 22.8% to $0.1255 after the FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test. SigmaTron International, Inc. (NASDAQ: SGMA) shares climbed 25.3% to $4.4861 after the company reported results for the fourth quarter. Pasithea Therapeutics Corp. (NASDAQ: KTTA) gained 21% to $0.5790 after the company rejected an unsolicited, non-binding acquisition proposal from Lucy Scientific Discovery. The company also authorized the repurchase of up to 5.7 million shares at $0.70/share. Kuke Music Holding Limited (NYSE: KUKE) climbed 16.5% to $0.55. Dynatronics Corporation (NASDAQ: DYNT) climbed 15% to $0.8998. Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares gained 14.4% to $0.5434 after gaining around 14% on Wednesday. Gorilla Technology Group Inc. (NASDAQ: GRRR) rose 14.4% to $2.61 after the company announced a strategic relationship with British Telecom to deliver an AI-powered innovative Smart Port solution. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) gained 12.3% to $22.59. Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) rose 11.6% to $3.54. Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 11.2% to $0.4099. Heritage-Crystal Clean, Inc (NASDAQ: HCCI) climbed 9.6% to $45.96 after the company announced it will be acquired by J.F. Lehman & Company for $1.2 billion. Zions Bancorporation, National Association (NASDAQ: ZION) rose 9.4% to $37.72 after the company reported second-quarter earnings results. Select Medical Holdings Corporation (NYSE: SEM) gained 9.1% to $32.87. Nanobiotix S.A. (NASDAQ: NBTX) shares climbed 8.4% to $7.77 as ...